CTLA4 and arthritic joint disease: Other toxicities included arthritis grade 3 (n = 2) and colitis grade 2 (n = 1), associated with single-agent anti-PD1 and colitis grade ≥2 (n = 8), associated with anti-CTLA4 (Figure 3D).